Showing results (311-320 of 324) with videos related to
Sort By:
Pageof 33
The Journal of Biological Chemistry|November 16, 2007
2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groupsKlaus Klumpp, Genadiy Kalayanov, Han Ma, et al.Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Design, synthesis, and antiviral properties of 4'-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479David B Smith, Joseph A Martin, Klaus Klumpp, et al.Blood Research|January 12, 2023
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)Christopher Chin Keong Liam, Jim Yu-Hsiang Tiao, Yee Yee Yap, et al.Oral Diseases|April 6, 2026
Immunohistochemical Expression of Invadopodia-Associated Proteins in Subtypes of Unicystic AmeloblastomaGabriela Cristina Avertano Rocha da Silveira, Rebeca Vieira Costa, Flavia Letícia Magalhães Lemos, et al.Annals of Emergency Medicine|February 1, 2017
Data Elements for Emergency Department Systems, Release 1.0 (DEEDS): A Summary ReportDaniel A Pollock, Diane L Adams, Lisa Marie Bernardo, et al.The New Phytologist|October 23, 2021
Evolutionary divergence in embryo and seed coat development of U's Triangle Brassica species illustrated by a spatiotemporal transcriptome atlasPeng Gao, Teagen D Quilichini, Hui Yang, et al.Chemmedchem|November 14, 2008
Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic propertiesZachary K Sweeney, Joshua J Kennedy-Smith, Jeffrey Wu, et al.Journal of Medicinal Chemistry|November 15, 2008
Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptaseZachary K Sweeney, Seth F Harris, Seth F Arora, et al.Nature Human Behaviour|May 13, 2024
Toolbox of individual-level interventions against online misinformationAnastasia Kozyreva, Philipp Lorenz-Spreen, Stefan M Herzog, et al.BMJ Open|April 23, 2021
Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisationJessica L Wisnowski, Stefan Bluml, Ashok Panigrahy, et al.Pageof 33